Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Greenhalf

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Gut|September 15, 2022
GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinomaMónica P de Andrés, Richard J Jackson, Irene Felipe, et al.
Neuroendocrinology|April 26, 2022
Genetically Determined Telomere Length Is Associated with Pancreatic Neuroendocrine Neoplasms OnsetManuel Gentiluomo, Gabriele Capurso, Luca Morelli, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 7, 2020
International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic ClubWilliam Greenhalf, Philippe Lévy, Thomas Gress, et al.
Cancers|November 27, 2021
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNAKaren Aughton, Nils O Elander, Anthony Evans, et al.
Gastroenterology|August 10, 2018
Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal AdenocarcinomaUjjwal Mukund Mahajan, Eno Langhoff, Elisabetta Goni, et al.
Carcinogenesis|January 9, 2018
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasmsOfure Obazee, Gabriele Capurso, Francesca Tavano, et al.
JNCI Cancer Spectrum|April 17, 2020
Cathepsin D Expression and Gemcitabine Resistance in Pancreatic CancerUjjwal M Mahajan, Elisabetta Goni, Enno Langhoff, et al.
The Journal of Antimicrobial Chemotherapy|June 16, 2026
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infectionSaye H Khoo, Richard FitzGerald, Christopher J Edwards, et al.
Gut|December 3, 2009
The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis familiesChristopher J Grocock, Vinciane Rebours, Myriam N Delhaye, et al.
Carcinogenesis|June 6, 2018
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasmsOfure Obazee, Gabriele Capurso, Francesca Tavano, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Gut|September 15, 2022
GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinomaMónica P de Andrés, Richard J Jackson, Irene Felipe, et al.
Neuroendocrinology|April 26, 2022
Genetically Determined Telomere Length Is Associated with Pancreatic Neuroendocrine Neoplasms OnsetManuel Gentiluomo, Gabriele Capurso, Luca Morelli, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 7, 2020
International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic ClubWilliam Greenhalf, Philippe Lévy, Thomas Gress, et al.
Cancers|November 27, 2021
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNAKaren Aughton, Nils O Elander, Anthony Evans, et al.
Gastroenterology|August 10, 2018
Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal AdenocarcinomaUjjwal Mukund Mahajan, Eno Langhoff, Elisabetta Goni, et al.
Carcinogenesis|January 9, 2018
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasmsOfure Obazee, Gabriele Capurso, Francesca Tavano, et al.
JNCI Cancer Spectrum|April 17, 2020
Cathepsin D Expression and Gemcitabine Resistance in Pancreatic CancerUjjwal M Mahajan, Elisabetta Goni, Enno Langhoff, et al.
The Journal of Antimicrobial Chemotherapy|June 16, 2026
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infectionSaye H Khoo, Richard FitzGerald, Christopher J Edwards, et al.
Gut|December 3, 2009
The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis familiesChristopher J Grocock, Vinciane Rebours, Myriam N Delhaye, et al.
Carcinogenesis|June 6, 2018
Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasmsOfure Obazee, Gabriele Capurso, Francesca Tavano, et al.
Pageof 13